{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:29:10Z","timestamp":1754144950917,"version":"3.41.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271993","82271971"],"award-info":[{"award-number":["82271993","82271971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"crossref","award":["21JCYBJC01640"],"award-info":[{"award-number":["21JCYBJC01640"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["TJYXZDXK-041A"],"award-info":[{"award-number":["TJYXZDXK-041A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04747-1","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:38:52Z","timestamp":1737783532000},"page":"3560-3571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computed tomography-based nomogram for estimating progression-free survival probability in bladder cancer patients undergoing partial cystectomy"],"prefix":"10.1007","volume":"50","author":[{"given":"Ting","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanchao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"issue":"1","key":"4747_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel R L, Miller K D, Wagle N S, Jemal A(2023) Cancer statistics (2023). CA Cancer J Clin 73(1):17-48. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4747_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat E M, Escrig J L D, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid A H, Palou J, van Rhijn B W G, Roupr\u00eat\u00a0M,\u00a0Shariat S F,\u00a0Seisen T,\u00a0Soukup V,\u00a0Sylvester R J(2022) European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81(1): 75-94. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010","journal-title":"Eur Urol"},{"issue":"4","key":"4747_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","volume":"22","author":"TW Flaig","year":"2024","unstructured":"Flaig T W,\u00a0Spiess P E\u00a0,\u00a0Abern M,\u00a0Agarwal N,\u00a0Bangs R,\u00a0Buyyounouski M K,\u00a0Chan K,\u00a0Chang S S,\u00a0Chang P,\u00a0Friedlander T,\u00a0Greenberg R E\u00a0,\u00a0Guru K A, Herr H W,\u00a0Hoffman-Censits J,\u00a0Kaimakliotis H,\u00a0Kishan A U,\u00a0Kundu S,\u00a0Lele S M,\u00a0Mamtani R,\u00a0Mian O Y,\u00a0Michalski J,\u00a0Montgomery J S,\u00a0Parikh M,\u00a0Patterson\u00a0A,\u00a0Peyton C,\u00a0Plimack E R,\u00a0Preston M A,\u00a0Richards K,\u00a0Sexton W J,\u00a0Siefker-Radtke A O,\u00a0Stewart T,\u00a0Sundi D,\u00a0Tollefson M,\u00a0Tward J,\u00a0Wright J L,\u00a0Cassara C J,\u00a0Gurski L A(2024) Bladder Cancer, Version 3.2024. J Natl Compr Canc Netw 22(4):216-225. https:\/\/doi.org\/10.6004\/jnccn.2024.0024","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4747_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"JA Witjes","year":"2024","unstructured":"Witjes J A, Bruins H M,\u00a0Carri\u00f3n A,\u00a0Cathomas R,\u00a0Comp\u00e9rat E,\u00a0Efstathiou J A,\u00a0Fietkau R,\u00a0Gakis G,\u00a0Lorch A,\u00a0Martini A,\u00a0Mertens L S,\u00a0Meijer R P,\u00a0Milowsky M I,\u00a0Neuzillet Y,\u00a0Panebianco V,\u00a0Redlef J,\u00a0Rink M,\u00a0Rouanne M,\u00a0Thalmann G N,\u00a0S\u00e6bj\u00f8rnsen S,\u00a0Veskim\u00e4e E,\u00a0Heijden A G(2024) European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol 85(1):17-31. https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016","journal-title":"Eur Urol"},{"key":"4747_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2021.03.010","author":"SL Maibom","year":"2021","unstructured":"Maibom S L,\u00a0R\u00f8der M A,\u00a0Poulsen A M,\u00a0Thind P O,\u00a0Salling M L,\u00a0Salling L N,\u00a0Kehlet H,\u00a0Brasso K,\u00a0Joensen U N(2021) Morbidity and Days Alive and Out of Hospital Within 90 Days Following Radical Cystectomy for Bladder Cancer. Eur Urol Open Sci 281-8. https:\/\/doi.org\/10.1016\/j.euros.2021.03.010","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"4747_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00345-016-1950-z","volume":"35","author":"H Djaladat","year":"2017","unstructured":"Djaladat H,\u00a0Katebian B,\u00a0Bazargani S T,\u00a0Miranda G,\u00a0Cai J,\u00a0Schuckman A K,\u00a0Daneshmand S(2017) 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol 35(6):907-911. https:\/\/doi.org\/10.1007\/s00345-016-1950-z","journal-title":"World J Urol"},{"issue":"2","key":"4747_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1590\/s1677-5538.ibju.2020.99.01","volume":"46","author":"J Hamad","year":"2020","unstructured":"Hamad J,\u00a0McCloskey H,\u00a0Milowsky M I,\u00a0Royce T,\u00a0Smith A(2020)\u00a0Bladder preservation in muscle-invasive bladder cancer: a comprehensive review. Int Braz J Urol 46(2):169-184. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2020.99.01","journal-title":"Int Braz J Urol"},{"issue":"4","key":"4747_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000472629","volume":"12","author":"J Kaneti","year":"1986","unstructured":"Kaneti J(1986) Partial cystectomy in the management of bladder carcinoma. Eur Urol 12(4):249-252. https:\/\/doi.org\/10.1159\/000472629","journal-title":"Eur Urol"},{"issue":"4","key":"4747_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/spc.0000000000000579","volume":"15","author":"T Goodstein","year":"2021","unstructured":"Goodstein T, Wang S J, Lee C T(2021) Bladder preservation in urothelial carcinoma: current trends and future directions. Curr Opin Support Palliat Care 15(4): 253-259. https:\/\/doi.org\/10.1097\/spc.0000000000000579","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"4747_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12894-023-01267-w","volume":"23","author":"B Zhang","year":"2023","unstructured":"Zhang B,\u00a0Liu T,\u00a0He Y,\u00a0Han D,\u00a0Qi P,\u00a0Zheng D,\u00a0Liu J,\u00a0Zhang X,\u00a0Yue Z,\u00a0Shang P(2023) Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer. BMC Urol 23(1):91. https:\/\/doi.org\/10.1186\/s12894-023-01267-w","journal-title":"BMC Urol"},{"issue":"4","key":"4747_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.urology.2009.03.052","volume":"74","author":"U Capitanio","year":"2009","unstructured":"Capitanio U,\u00a0Isbarn H,\u00a0Shariat S F,\u00a0Jeldres C,\u00a0Zini L,\u00a0Saad F,\u00a0Graefen M,\u00a0Montorsi F,\u00a0Perrotte P,\u00a0Karakiewicz P I(2009) Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. Urology 74(4):858-864. https:\/\/doi.org\/10.1016\/j.urology.2009.03.052","journal-title":"Urology"},{"issue":"12","key":"4747_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5489\/cuaj.4403","volume":"11","author":"MJ Leveridge","year":"2017","unstructured":"Leveridge M J,\u00a0Siemens D R,\u00a0Izard J P,\u00a0Wei X,\u00a0Booth C M(2017) Partial cystectomy for urothelial carcinoma of the bladder: Practice patterns and outcomes in the general population. Can Urol Assoc J 11(12):412-418. https:\/\/doi.org\/10.5489\/cuaj.4403","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"4747_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.clgc.2019.09.008","volume":"18","author":"FA Mistretta","year":"2020","unstructured":"Mistretta F A, Cyr S J, Luzzago S, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat S F, de Cobelli O, Karakiewicz P I(2020) Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. Clin Genitourin Cancer 18(2):129-137.e3. https:\/\/doi.org\/10.1016\/j.clgc.2019.09.008","journal-title":"Clin Genitourin Cancer"},{"issue":"10","key":"4747_CR14","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ejso.2013.04.006","volume":"39","author":"B Ma","year":"2013","unstructured":"Ma B,\u00a0Li H,\u00a0Zhang C,\u00a0Yang K,\u00a0Qiao B,\u00a0Zhang Z,\u00a0Xu Y(2013) Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Eur J Surg Oncol 39(10) :1150-1156. https:\/\/doi.org\/10.1016\/j.ejso.2013.04.006","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"4747_CR15","doi-asserted-by":"publisher","first-page":"8360","DOI":"10.1038\/s41598-018-26089-x","volume":"8","author":"J Ebbing","year":"2018","unstructured":"Ebbing J,\u00a0Heckmann R C,\u00a0Collins J W,\u00a0Miller K,\u00a0Erber B,\u00a0Friedersdorff F,\u00a0Fuller T F,\u00a0Busch J,\u00a0Seifert H H,\u00a0Ardelt P,\u00a0Wetterauer C,\u00a0Hosseini A,\u00a0Jentzmik F,\u00a0Kempkensteffen C(2018) Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer. Sci Rep 8(1):8360. https:\/\/doi.org\/10.1038\/s41598-018-26089-x","journal-title":"Sci Rep"},{"key":"4747_CR16","doi-asserted-by":"publisher","first-page":"2665711","DOI":"10.1155\/2022\/2665711","volume":"2022","author":"X Zhan","year":"2022","unstructured":"Zhan X,\u00a0Chen T,\u00a0Jiang M,\u00a0Deng W,\u00a0Liu X,\u00a0Chen L,\u00a0Fu B(2022) A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Muscle-Invasive Bladder Cancer Patients after Partial Cystectomy. J Oncol 2022: 2665711. https:\/\/doi.org\/10.1155\/2022\/2665711","journal-title":"J Oncol"},{"issue":"6","key":"4747_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11547-022-01488-3","volume":"127","author":"G Ascenti","year":"2022","unstructured":"Ascenti G,\u00a0Cicero G,\u00a0Bertelli E,\u00a0Papa M,\u00a0Gentili F,\u00a0Ciccone V,\u00a0Manetta R,\u00a0Gandolfo N,\u00a0Cardone G,\u00a0Miele V(2022) CT-urography: a nationwide survey by the Italian Board of Urogenital Radiology. Radiol Med 127(6):577-588. https:\/\/doi.org\/10.1007\/s11547-022-01488-3","journal-title":"Radiol Med"},{"issue":"6","key":"4747_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2214\/ajr.16.17114","volume":"208","author":"CH Lee","year":"2017","unstructured":"Lee C H,\u00a0Tan C H,\u00a0Faria S de C,\u00a0Kundra V(2017) Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder. AJR Am J Roentgenol 208(6):1193-1205. https:\/\/doi.org\/10.2214\/ajr.16.17114","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"4747_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00261-023-04069-8","volume":"49","author":"KA Kang","year":"2024","unstructured":"Kang K A,\u00a0Kim M J,\u00a0Kwon G Y,\u00a0Kim C K,\u00a0Park S Y(2024) Computed tomography-based prediction model for identifying patients with high probability of non-muscle-invasive bladder cancer. Abdom Radiol (NY) 49(1):163-172. https:\/\/doi.org\/10.1007\/s00261-023-04069-8","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"4747_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12880-024-01276-7","volume":"24","author":"R Zhang","year":"2024","unstructured":"Zhang R,\u00a0Jia S,\u00a0Zhai L,\u00a0Wu F,\u00a0Zhang S,\u00a0Li F(2024) Predicting preoperative muscle invasion status for bladder cancer using computed tomography-based radiomics nomogram. BMC Med Imaging 24(1):98. https:\/\/doi.org\/10.1186\/s12880-024-01276-7","journal-title":"BMC Med Imaging"},{"issue":"13","key":"4747_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/diagnostics13132227","volume":"13","author":"A Borgheresi","year":"2023","unstructured":"Borgheresi A,\u00a0Agostini A,\u00a0Sternardi F,\u00a0Cesari E,\u00a0Ventura F,\u00a0Ottaviani L,\u00a0Delle Fave R F,\u00a0Pretore E,\u00a0Cimadamore A, Filosa A,\u00a0Galosi A B,\u00a0Giovagnoni A(2023) Vascular Enlargement as a Predictor of Nodal Involvement in Bladder Cancer. Diagnostics (Basel) 13(13):2227. https:\/\/doi.org\/10.3390\/diagnostics13132227","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"4747_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12894-024-01459-y","volume":"24","author":"P Jin","year":"2024","unstructured":"Jin P,\u00a0Yang L,\u00a0Liu Y,\u00a0Huang J,\u00a0Wang X(2024) Quantitative differentiation of non-invasive bladder urothelial carcinoma and inverted papilloma based on CT urography. BMC Urol 24(1):73. https:\/\/doi.org\/10.1186\/s12894-024-01459-y","journal-title":"BMC Urol"},{"issue":"20","key":"4747_CR23","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1002\/sim.8137","volume":"38","author":"C Wang","year":"2019","unstructured":"Wang C,\u00a0Li Q,\u00a0Song X,\u00a0Dong X(2019) Bayesian adaptive lasso for additive hazard regression with current status data. Stat Med 38(20):3703-3718. https:\/\/doi.org\/10.1002\/sim.8137","journal-title":"Stat Med"},{"key":"4747_CR24","doi-asserted-by":"publisher","first-page":"702653","DOI":"10.1155\/2014\/702653","volume":"2014","author":"WM Bazzi","year":"2014","unstructured":"Bazzi W M,\u00a0Kopp R P,\u00a0Donahue T F,\u00a0Bernstein M,\u00a0Russo P,\u00a0Bochner B H,\u00a0Donat S M,\u00a0Dalbagni G,\u00a0Herr H W(2014) Partial Cystectomy after Neoadjuvant Chemotherapy: Memorial Sloan Kettering Cancer Center Contemporary Experience. Int Sch Res Notices 2014: 702653. https:\/\/doi.org\/10.1155\/2014\/702653","journal-title":"Int Sch Res Notices"},{"issue":"1","key":"4747_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12935-022-02575-1","volume":"22","author":"X Li","year":"2022","unstructured":"Li X,\u00a0Zhang C,\u00a0Peng X,\u00a0Li Y,\u00a0Chen G,\u00a0Gou X,\u00a0Zhou X,\u00a0Ma C(2022) A novel risk score model based on five angiogenesis-related long non-coding RNAs for bladder urothelial carcinoma. Cancer Cell Int 22(1):157. https:\/\/doi.org\/10.1186\/s12935-022-02575-1","journal-title":"Cancer Cell Int"},{"issue":"2","key":"4747_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/path.4892","volume":"242","author":"F Roudnicky","year":"2017","unstructured":"Roudnicky F,\u00a0Dieterich L C,\u00a0Poyet C,\u00a0Buser L,\u00a0Wild P,\u00a0Tang D,\u00a0Camenzind P,\u00a0Ho C H,\u00a0Otto V I,\u00a0Detmar M(2017) High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival. J Pathol 242(2):193-205. https:\/\/doi.org\/10.1002\/path.4892","journal-title":"J Pathol"},{"issue":"2","key":"4747_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.rcl.2016.10.008","volume":"55","author":"SP Raman","year":"2017","unstructured":"Raman S P,\u00a0Fishman E K(2017) Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography. Radiol Clin North Am 55(2):225-241. https:\/\/doi.org\/10.1016\/j.rcl.2016.10.008","journal-title":"Radiol Clin North Am"},{"key":"4747_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.12659\/pjr.896752","volume":"81","author":"II Oz","year":"2016","unstructured":"Oz I I,\u00a0Altinbas N K,\u00a0Serifoglu I,\u00a0Oz E B,\u00a0Yagci C (2016) The Role of Computerized Tomography in the Assessment of Perivesical Invasion in Bladder Cancer, Pol J Radiol 81:281-287. https:\/\/doi.org\/10.12659\/pjr.896752","journal-title":"Pol J Radiol"},{"issue":"6","key":"4747_CR29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00345-020-03375-w","volume":"39","author":"JG Fuletra","year":"2021","unstructured":"Fuletra J G, Watts A, Kaag M G, Lehman E, Raman J D, Merrill S B(2021) Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy. World J Urol 39(6): 1941-1945. https:\/\/doi.org\/10.1007\/s00345-020-03375-w","journal-title":"World J Urol"},{"issue":"1","key":"4747_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1148\/radiology.193.1.8090898","volume":"193","author":"B Kim","year":"1994","unstructured":"Kim B,\u00a0Semelka R C,\u00a0Ascher S M,\u00a0Chalpin D B,\u00a0Carroll P R,\u00a0Hricak H(1994) Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 193(1): 239-245. https:\/\/doi.org\/10.1148\/radiology.193.1.8090898","journal-title":"Radiology"},{"issue":"1","key":"4747_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten F R,\u00a0Grivennikov S I(2019) Inflammation and Cancer: Triggers, Mechanisms, and Consequences. Immunity 51(1): 27-41. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"issue":"4","key":"4747_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cncr.28416","volume":"120","author":"JA Cohn","year":"2014","unstructured":"Cohn J A, Vekhter B, Lyttle C, Steinberg G D, Large M C(2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120(4):555-561. https:\/\/doi.org\/10.1002\/cncr.28416","journal-title":"Cancer"},{"issue":"1","key":"4747_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.urology.2007.03.033","volume":"70","author":"MJ Wasco","year":"2007","unstructured":"Wasco M J,\u00a0Daignault S,\u00a0Zhang Y,\u00a0Kunju L P,\u00a0Kinnaman M,\u00a0Braun T,\u00a0Lee C T,\u00a0Shah R B(2007) Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70(1): 69-74. https:\/\/doi.org\/10.1016\/j.urology.2007.03.033","journal-title":"Urology"},{"issue":"4","key":"4747_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.juro.2012.10.054","volume":"189","author":"AA El-Latif","year":"2013","unstructured":"El-Latif A A,\u00a0Watts K E,\u00a0Elson P,\u00a0Fergany A,\u00a0Hansel D E(2013) The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy. J Urol 189(4):1263-1267. https:\/\/doi.org\/10.1016\/j.juro.2012.10.054","journal-title":"J Urol"},{"issue":"1","key":"4747_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey P A,\u00a0Moch H,\u00a0Cubilla A L,\u00a0Ulbright T M,\u00a0Reuter V E(2016) The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. Eur Urol 70(1) :106-119. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028","journal-title":"Eur Urol"},{"issue":"1","key":"4747_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.semradonc.2022.10.008","volume":"33","author":"A Brocklehurst","year":"2023","unstructured":"Brocklehurst A,\u00a0Varughese M,\u00a0Birtle A(2023) Bladder Preservation for Muscle-Invasive Bladder Cancer With Variant Histology. Semin Radiat Oncol. 33(1):62-69. https:\/\/doi.org\/10.1016\/j.semradonc.2022.10.008","journal-title":"Semin Radiat Oncol."},{"issue":"1","key":"4747_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.eururo.2016.12.002","volume":"72","author":"RE Krasnow","year":"2017","unstructured":"Krasnow R E, Drumm M, Roberts H J,\u00a0Niemierko A,\u00a0Wu\u00a0C L,\u00a0Wu S,\u00a0Zhang J,\u00a0Heney N M,\u00a0Wszolek M F,\u00a0Blute M L,\u00a0Feldman A S,\u00a0Lee\u00a0R J,\u00a0Zietman A L,\u00a0Shipley\u00a0W U,\u00a0Efstathiou\u00a0J A(2017) Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. Eur Urol 72(1):54-60. https:\/\/doi.org\/10.1016\/j.eururo.2016.12.002","journal-title":"Eur Urol"},{"issue":"2","key":"4747_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.juro.2012.04.020","volume":"188","author":"SP Kim","year":"2012","unstructured":"Kim S P,\u00a0Frank L, Cheville J C, Thompson R H, Weight C J, Thapa P, Boorjian S A(2012) The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma. J Urol. 188(2):405-409. https:\/\/doi.org\/10.1016\/j.juro.2012.04.020","journal-title":"J Urol"},{"issue":"2","key":"4747_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.urolonc.2012.04.020","volume":"32","author":"AS Fairey","year":"2014","unstructured":"Fairey A S,\u00a0Daneshmand S,\u00a0Wang L,\u00a0Schuckman A,\u00a0Lieskovsky G,\u00a0Djaladat H,\u00a0Cai J,\u00a0Miranda G,\u00a0Skinner E C(2014) Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol. 32(2):110-116. https:\/\/doi.org\/10.1016\/j.urolonc.2012.04.020","journal-title":"Urol Oncol."},{"issue":"5","key":"4747_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1464-410x.2010.09900.x","volume":"108","author":"E Scosyrev","year":"2011","unstructured":"Scosyrev E,\u00a0Ely B W,\u00a0Messing E M,\u00a0Speights V O,\u00a0Grossman H B,\u00a0Wood D P,\u00a0de Vere White R W,\u00a0Vogelzang N J,\u00a0Trump D L,\u00a0Natale R B,\u00a0Tangen C M,\u00a0Crawford E D,\u00a0Thompson I M(2011) Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710). BJU Int 108(5): 693-699. https:\/\/doi.org\/10.1111\/j.1464-410x.2010.09900.x","journal-title":"BJU Int"},{"issue":"4","key":"4747_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1464-410x.2011.10357.x","volume":"109","author":"F Abdollah","year":"2012","unstructured":"Abdollah F,\u00a0Sun M,\u00a0Jeldres C,\u00a0Schmitges J,\u00a0Thuret R,\u00a0Djahangirian O,\u00a0Tian Z,\u00a0Shariat S F,\u00a0Perrotte P,\u00a0Montorsi F,\u00a0Karakiewicz P I(2012) Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. BJU Int 109(4):564-569. https:\/\/doi.org\/10.1111\/j.1464-410x.2011.10357.x","journal-title":"BJU Int"},{"issue":"26","key":"4747_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ctro.2020.11.002","volume":"9","author":"JR Janopaul-Naylor","year":"2021","unstructured":"Janopaul-Naylor J R,\u00a0Zhong J,\u00a0Liu Y,\u00a0Zhang C,\u00a0Osunkoya A O,\u00a0Joshi S S,\u00a0Bilen M A,\u00a0Carthon B,\u00a0Kucuk O,\u00a0Hartsell L M,\u00a0Shelton J,\u00a0Jani A B(2021) Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database. Clin Transl Radiat Oncol. 9:26:30-34. https:\/\/doi.org\/10.1016\/j.ctro.2020.11.002","journal-title":"Clin Transl Radiat Oncol."},{"issue":"4","key":"4747_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.ijrobp.2021.02.003","volume":"110","author":"C Chau","year":"2021","unstructured":"Chau C, Rimmer Y, Choudhury A, Leaning D, Law A, Enting D, Lim J H, Hafeez S, Khoo V, Huddart R, Mitchell D, Henderson D R, McGrane J, Beresford M, Vasudev N, Beesley S, Hilman S, Manetta C, Sriram R, Sharma A, Eswar C, Treece S, Vilarino-Varela M, Varughese M, Glen H, Pintus E, Crabb A(2021) Treatment Outcomes for Small Cell Carcinoma of the Bladder: Results From a UK Patient Retrospective Cohort Study. Int J Radiat Oncol Biol Phys 110(4):1143-1150. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.02.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"4747_CR44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/jjco\/hyaa155","volume":"50","author":"T Kimura","year":"2020","unstructured":"Kimura T,\u00a0Ishikawa H,\u00a0Kojima T,\u00a0Kandori S,\u00a0Kawahara T,\u00a0Sekino Y,\u00a0SakuraI H,\u00a0Nishiyama H (2020) Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future. Jpn J Clin Oncol 50(10) :1097-1107. https:\/\/doi.org\/10.1093\/jjco\/hyaa155","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"4747_CR45","doi-asserted-by":"publisher","first-page":"e24878","DOI":"10.1016\/j.heliyon.2024.e24878","volume":"10","author":"Z Wei","year":"2024","unstructured":"Wei Z, Liu H, Xv Y, Liao F, He Q, Xie, Y, Lv F, Jiang Q, Xiao M(2024) Development and validation of a CT-based deep learning radiomics nomogram to predict muscle invasion in bladder cancer. Heliyon 10(2):e24878. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24878","journal-title":"Heliyon"},{"issue":"18","key":"4747_CR46","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.3390\/cancers14184449","volume":"14","author":"P Wo\u017anicki","year":"2022","unstructured":"Wo\u017anicki P, Laqua F C, Messmer K, Kunz W G, Stief C, N\u00f6renberg D, Schreier A, W\u00f3jcik J, Ruebenthaler J, Ingrisch M, Ricke J, Buchner A, Schulz G B, Gresser E(2022). Radiomics for the Prediction of Overall Survival in Patients with Bladder Cancer Prior to Radical Cystectomy. Cancers (Basel) 14(18):4449. https:\/\/doi.org\/10.3390\/cancers14184449","journal-title":"Cancers (Basel)"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04747-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04747-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T06:20:49Z","timestamp":1752646849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04747-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4747"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04747-1","relation":{},"ISSN":["2366-0058"],"issn-type":[{"type":"electronic","value":"2366-0058"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}